tm logo
PYRAMID DESIGN
REGISTERED

on 11 Jun 2020

Last Applicant/ Owned by

NOVARTIS AG

4002 BASEL

CH

Serial Number

1920494 filed on 18th Sep 2018

Registration Number

TMA1079572 registered on 11th Jun 2020

Registration expiry Date

11th Jun 2030

Correspondent Address

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

PYRAMID DESIGN

Vienna Information


26 . 5 . 2

Two polygons, one inside the other (except 26.5.10 and 26.5.11)Deux polygones, l'un dans l'autre (excepté 26.5.10 et 26.5.11)

26 . 5 . 24

Polygons with dark surfaces or parts of surfacesPolygones avec surface ou partie de la surface foncée

26 . 4 . 4

Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis

26 . 4 . 9

Several quadrilaterals juxtaposed, joined or intersectingPlusieurs quadrilatères, juxtaposés, accolés ou se coupant

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

26 . 7 . 19

Quadrilaterals with one or more polygons other than trianglesQuadrilatères avec un ou plusieurs polygones autres que les triangles

26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

Trademark usage description

pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue disease, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, anti-bacterials, antivirals, anti-biotics, systemic and topical anti-fungals


Classification kind code

11

Mark Details


Serial Number

1920494

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 22nd Jan 2020
Registration Pending
Submitted for opposition 191
on 22nd Jan 2020
Registration Fee Notice Sent
Submitted for opposition 42
on 30th Oct 2019
Advertised
Submitted for opposition 22
on 10th Oct 2019
Search Recorded
Submitted for opposition 26
on 10th Oct 2019
Approved
Submitted for opposition 27
on 10th Oct 2019
Approval Notice Sent
Submitted for opposition 67
on 11th Sep 2019
Agent Name Changed
Submitted for opposition 31
on 25th Sep 2018
Formalized
Submitted for opposition 1
on 19th Sep 2018
Created
Submitted for opposition 30
on 18th Sep 2018
Filed